Mahmoud E. S. Soliman - Search Results

Year	Number of Results
2008	1
2009	2
2011	3
2012	8
2013	6
2014	7
2015	10
2016	14
2017	14
2018	24
2019	29
2020	29
2021	33
2022	38
2023	21
2024	1

1

Exploring the composition of protein-ligand binding sites for cancerous inhibitor of PP2A (CIP2A) by inhibitor guided binding analysis: paving a new way for the Discovery of drug candidates against triple negative breast cancer (TNBC).

Ibitoye O, Ibrahim MAA, Soliman MES. Ibitoye O, et al. Among authors: soliman mes. J Recept Signal Transduct Res. 2023 Dec;43(6):133-143. doi: 10.1080/10799893.2023.2298903. Epub 2024 Feb 13. J Recept Signal Transduct Res. 2023. PMID: 38166612

2

Multi-cavity molecular descriptor interconnections: Enhanced protocol for prediction of serum albumin drug binding.

Akawa OB, Okunlola FO, Alahmdi MI, Abo-Dya NE, Sidhom PA, Ibrahim MAA, Shibl MF, Khan S, Soliman MES. Akawa OB, et al. Among authors: soliman mes. Eur J Pharm Biopharm. 2024 Jan;194:9-19. doi: 10.1016/j.ejpb.2023.11.003. Epub 2023 Nov 19. Eur J Pharm Biopharm. 2024. PMID: 37984594

3

Exploring the potential of biologically active phenolic acids from marine natural products as anticancer agents targeting the epidermal growth factor receptor.

Roney M, Issahaku AR, Huq AM, Soliman MES, Tajuddin SN, Aluwi MFFM. Roney M, et al. Among authors: soliman mes. J Biomol Struct Dyn. 2023 Nov 1:1-24. doi: 10.1080/07391102.2023.2276879. Online ahead of print. J Biomol Struct Dyn. 2023. PMID: 37909584

4

Selected phytochemicals of Momordica charantia L. as potential anti-DENV-2 through the docking, DFT and molecular dynamic simulation.

Huq AKMM, Roney M, Issahaku AR, Sapari S, Ilyana Abdul Razak F, Soliman MES, Mohd Aluwi MFF, Tajuddin SN. Huq AKMM, et al. Among authors: soliman mes. J Biomol Struct Dyn. 2023 Sep 7:1-12. doi: 10.1080/07391102.2023.2251069. Online ahead of print. J Biomol Struct Dyn. 2023. PMID: 37676311

5

Investigation of Simultaneous and Sequential Cooperative Homotropic Inhibitor Binding to the Catalytic Chamber of SARS-CoV-2 RNA-dependent RNA Polymerase (RdRp).

Metwally K, Abo-Dya NE, Hamdan AME, Alrashidi MN, Alturki MS, Aly OM, Aljoundi A, Ibrahim M, Soliman MES. Metwally K, et al. Among authors: soliman mes. Cell Biochem Biophys. 2023 Dec;81(4):697-706. doi: 10.1007/s12013-023-01163-y. Epub 2023 Sep 2. Cell Biochem Biophys. 2023. PMID: 37658974

6

Therapeutic Path to Triple Knockout: Investigating the Pan-inhibitory Mechanisms of AKT, CDK9, and TNKS2 by a novel 2-Phenylquinazolinone derivative in Cancer Therapy- An In-Silico Investigation.

Peters XQ, Elamin G, Aljoundi A, Alahmdi MI, Abo-Dya NE, Sidhom PA, Tawfeek AM, Ibrahim MAA, Soremekun O, Soliman MES. Peters XQ, et al. Among authors: soliman mes. Curr Pharm Biotechnol. 2023 Aug 15. doi: 10.2174/1389201024666230815145001. Online ahead of print. Curr Pharm Biotechnol. 2023. PMID: 37581526

7

A novel small molecule inhibitor of p38⍺ MAP kinase augments cardiomyocyte cell cycle entry in response to direct cell cycle stimulation.

Abouleisa RRE, Miller JM, Gebreil A, Salama ABM, Dwenger M, Abdelhafez H, Wahid RM, Adewumi AT, Soliman MES, Abo-Dya NE, Mohamed TMA. Abouleisa RRE, et al. Among authors: soliman mes. Br J Pharmacol. 2023 Dec;180(24):3271-3289. doi: 10.1111/bph.16209. Epub 2023 Aug 30. Br J Pharmacol. 2023. PMID: 37547998

8

Multi-dimensional structural footprint identification for the design of potential scaffolds targeting METTL3 in cancer treatment from natural compounds.

Issahaku AR, Mncube SM, Agoni C, Kwofie SK, Alahmdi MI, Abo-Dya NE, Sidhom PA, Tawfeek AM, Ibrahim MAA, Mukelabai N, Soremekun O, Soliman MES. Issahaku AR, et al. Among authors: soliman mes. J Mol Model. 2023 Mar 30;29(4):122. doi: 10.1007/s00894-023-05516-5. J Mol Model. 2023. PMID: 36995499

9

In silico evaluation of usnic acid derivatives to discover potential antibacterial drugs against DNA gyrase B and DNA topoisomerase IV.

Roney M, Issahaku AR, Forid MS, Huq AKMM, Soliman MES, Mohd Aluwi MFF, Tajuddin SN. Roney M, et al. Among authors: soliman mes. J Biomol Struct Dyn. 2023;41(24):14904-14913. doi: 10.1080/07391102.2023.2193996. Epub 2023 Mar 30. J Biomol Struct Dyn. 2023. PMID: 36995164

10

Artificial Intelligence, Machine Learning, and Big Data for Ebola Virus Drug Discovery.

Kwofie SK, Adams J, Broni E, Enninful KS, Agoni C, Soliman MES, Wilson MD. Kwofie SK, et al. Among authors: soliman mes. Pharmaceuticals (Basel). 2023 Feb 21;16(3):332. doi: 10.3390/ph16030332. Pharmaceuticals (Basel). 2023. PMID: 36986432 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

200 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Results by year